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Abstract
Influenza A virus pandemics and emerging anti-viral resistance highlight the urgent need for novel generic pharmacological
strategies that reduce both viral replication and lung inflammation. We investigated whether the primary enzymatic source
of inflammatory cell ROS (reactive oxygen species), Nox2-containing NADPH oxidase, is a novel pharmacological target
against the lung inflammation caused by influenza A viruses. Male WT (C57BL/6) and Nox22/y mice were infected
intranasally with low pathogenicity (X-31, H3N2) or higher pathogenicity (PR8, H1N1) influenza A virus. Viral titer, airways
inflammation, superoxide and peroxynitrite production, lung histopathology, pro-inflammatory (MCP-1) and antiviral (IL-1b)
cytokines/chemokines, CD8+ T cell effector function and alveolar epithelial cell apoptosis were assessed. Infection of Nox22/y
mice with X-31 virus resulted in a significant reduction in viral titers, BALF macrophages, peri-bronchial inflammation, BALF
inflammatory cell superoxide and lung tissue peroxynitrite production, MCP-1 levels and alveolar epithelial cell apoptosis
when compared to WT control mice. Lung levels of IL-1b were ,3-fold higher in Nox22/y mice. The numbers of influenza-
specific CD8+DbNP366+ and DbPA224+ T cells in the BALF and spleen were comparable in WT and Nox22/y mice. In vivo
administration of the Nox2 inhibitor apocynin significantly suppressed viral titer, airways inflammation and inflammatory cell
superoxide production following infection with X-31 or PR8. In conclusion, these findings indicate that Nox2 inhibitors have
therapeutic potential for control of lung inflammation and damage in an influenza strain-independent manner.
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Introduction
The early host innate immune response directed against
influenza A virus infection in the absence of pre-existing immunity
is typically characterised by activation of airway epithelium and
resident alveolar macrophages, and release of inflammatory
mediators resulting in the trafficking of additional macrophages,
neutrophils and T lymphocytes into the lung [1]. The recruitment
of macrophages and neutrophils into the lung controls seasonal
influenza virus and results in mild clinical symptoms. However,
some pandemic influenza A viruses initiate an aggressive persistent
trafficking of large numbers of inflammatory cells, which is now
considered to be associated with lethal disease, culminating in
severe lung injury as seen for H5N1 and 1918 pandemic influenza
virus infection [2].
Recent evidence suggests that much of the acute lung injury
caused by H5N1 can be attributed to excessive ROS production
(i.e. oxidative stress) initiated by an overactive innate immune
response [3], [4]. ROS including superoxide anion and its
derivatives peroxynitrite (OONO2), hydrogen peroxide (H2O2)
and hydroxyl radical (OH.) are indiscriminately toxic to cells when
produced in excess and capable of regulating pro-inflammatory
cytokine production. The cellular source of ROS is most likely to
be infiltrating inflammatory cells, which on a cell-to-cell basis
generate more ROS than any other cell type [5], [6].
Identification of the enzymatic sources of ROS may pave the
way for therapies that combat the oxidative stress-dependent lung
injury caused by influenza A virus infection.
A number of enzyme systems expressed in mammalian cells are
capable of generating superoxide (for reviews see [5], [6]).
However, NADPH oxidase is the primary source of superoxide
production by inflammatory cells [5], [6]. The inflammatory cell
NADPH oxidase enzyme consists of a number of protein subunits
including the catalytic subunit Nox2, the smaller a-subunit,
p22phox, as well as multiple regulatory subunits, including the
organizer protein p47phox, the activator protein p67phox, p40phox
and the small G protein Rac1. Nox2 was recently shown to play a
role in the clearance of influenza infection and in lung dysfunction
[7]. However, it remains to be determined if Nox2 influences: (i)
low and high pathogenicity influenza A virus infection, (ii) the
infiltration of sub-populations of inflammatory cells into the
airways, (iii) superoxide and peroxynitrite production by key
inflammatory cells in the airways, (iv) alveolar epithelial cell
apoptosis, (v) the levels of potential antiviral nitric oxide (NO)
generated and (vi) crucial adaptive immune responses that clear
influenza virus. Moreover, it is unknown if pharmacological
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inhibitors of Nox2 protect against influenza virus-induced airways
inflammation and damage. The present study clearly shows that
Nox2 is critical for the control of influenza infection and that
inhibition of Nox2 may be a way of controlling future pandemics
by modulating the host instead of the virus.
Results
Nox22/y mice show reduced BALF inflammation in
response to X-31 virus
Naı¨ve (i.e. no virus) Nox22/y mice had similar total cell
numbers in the BALF to naı¨ve WT mice (Figure 1A). We then
analysed the extent of cellular infiltration in the BALF of WT and
Nox22/y mice infected with X-31 virus 3 and 7 days post
infection. Three days following infection, the cellular infiltrate in
WT mice increased by ,12.5 fold from basal levels (Figure 1A),
which was similar in Nox22/y mice (Figure 1A). However, by Day
7 post infection, the total number of cells in Nox22/y mice was
significantly lower (,40%, P,0.05) when compared to WT
controls (Figure 1A).
Close analyses of the infiltrating and resident populations by
differential cell counting revealed that both 3 and 7 days post X-31
infection, BALF from Nox22/y mice contained significantly less
(P,0.05) macrophages than WT mice (Figure 1B). There was a
trend for neutrophil numbers to be higher in Nox22/y mice
compared to WT mice infected with X-31 although this was not
statistically significant (Figure 1C).
Histological investigation of lung inflammation in X-31
infected Nox22/y mice
We also examined the degree of airway inflammation caused by
X-31 in H&E stained lung sections from WT and Nox22/y mice
killed at Day 3 post infection. We chose this time point to examine
the lung inflammation as we have previously shown this to
Author Summary
Influenza A virus pandemics are imminent and with
emerging anti-viral resistance highlight an ongoing,
urgent need for novel generic pharmacological strategies.
Ideally these strategies should reduce both viral replication
and lung inflammation, irrespective of the infecting strain by
modulating the host immune response. An important
paradigm strongly suggests that the lung damage arising
from not only influenza A viruses but other pathogens
including, but not restricted to, SARS, parainfluenza
viruses, human respiratory syncytial virus and Streptococcus
pneumoniae consists of an excessive host response
characterised by a rapid, influx of inflammatory cells into
the lungs leading to excessive reactive oxygen species
(ROS) production. Our study demonstrates that the
primary enzymatic source of inflammatory cell ROS,
Nox2-containing NADPH oxidase, promotes airways in-
flammation to low and high pathogenicity influenza A
virus infection and impedes with the host’s ability to clear
the virus. Thus, Nox2 inhibitors could be considered
individually or in combination with current antiviral
strategies for control of future influenza A virus pandemics.
Figure 1. Effect of H3N2 (X-31) influenza A virus infection on BALF cellularity in wild type (WT) and Nox22/y mice. Mice were treated
with 16104 PFU of the low virulence H3N2 strain of influenza A virus and the number of (A) total cells, (B) macrophages and (C) neutrophils counted
in the BALF 3 and 7 days post infection. Data are shown as mean6 SD for 6–8 mice per group. *P,0.05 vs respective no virus group,#P,0.05 vs D3
X-31-treated WT mice mice, ‘P,0.05 vs D7 X-31-treated WT mice (ANOVA and Dunnett’s post hoc test).
doi:10.1371/journal.ppat.1001271.g001
Nox2 Oxidase and Influenza A Virus
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represent the peak of airways inflammation and viral load
following X-31 virus infection [8]. Lungs from WT mice had
obvious peri-bronchial inflammation and prominent bronchial
infiltrates consisting of mononuclear cells and neutrophils
(Figure 2A, B). In contrast, histological examination of Nox22/y
mice showed considerably less bronchial cell infiltrate and peri-
bronchial inflammation (Figure 2C, D).
Nox2 is the primary source of superoxide and
peroxynitrite production
We examined basal and phorbol dibutyrate (PDB)-stimulated
superoxide production by inflammatory cells in BALF of naı¨ve and
X-31-infected WT and Nox22/y mice. BALF cells isolated from
naı¨ve WT mice produced superoxide under basal conditions (data
not shown), which was increased in the presence of PDB
stimulation (Figure 3). In comparison, BALF cells isolated from
naı¨ve Nox22/y mice produced very little superoxide under both
basal conditions (not shown) and following PDB stimulation
(Figure 3). Ex vivo treatment of BALF cells with SOD (300U/ml)
significantly reduced the chemiluminescence signal at 3 days
following infection confirming that chemiluminescence resulted
from superoxide detection (data not shown). BALF inflammatory
cells from WT mice infected with X-31 produced significantly
higher amounts (,7-fold) of basal (not shown) and PDB-stimulated
superoxide than BALF cells obtained from naı¨ve mice (Figure 3).
Again, superoxide production was virtually abolished in BALF
cells isolated from lungs of Nox22/y mice (Figure 3).
Superoxide gives rise to toxic reactive nitrogen species such as
peroxynitrite when it reacts rapidly with NO. Thus, we examined
3-nitrotyrosine immunofluorescence as a measure of peroxynitrite
production. Lung sections from WT mice infected with X-31
displayed strong immunofluorescence for 3-nitrotyrosine in the
inflammatory cells that infiltrated the airways, as well as in the
alveolar tissue (Figures 4A and C). By contrast, little immunoflu-
orescence was observed in similar lung sections obtained from
Nox22/y mice infected with X-31 (Figures 4B and D).
Effect of Nox2 deletion on viral titers and body weight
To determine if reduced inflammation of Nox22/y mice
correlated with lower levels of virus, we measured lung virus titers
using the plaque assay. Lung virus titers were significantly lower
(,45%, P,0.05) in Nox22/y mice than WT mice at the day 3
time-point (Figure 5A). We explored whether Nox2 deletion had
an impact on X-31-induced body weight loss. WT and Nox22/y
mice lost similar amounts of weight following X-31 infection
(Figure 5B).
Determination of NO levels in BALF
We hypothesized that the enhanced clearance of virus from the
lungs of Nox22/y mice could be attributed to an enhanced level of
NO in the absence of superoxide. To address this we measured
nitrite levels in BALF using the Griess reaction 3 days after X-31
infection. BALF from Nox22/y mice had similar levels of nitrite
(26.4264.37 mM), and thus NO, to WT mice (22.0564.48 mM)
(P=0.08; n= 9).
Nox2 and apoptosis
Accumulating evidence suggests that apoptosis of lung alveolar
epithelial cells underlies alveolar injury and lung leakage, which
are hallmarks of the acute lung injury/primary pneumonia
following influenza A virus infection. Thus, we examined alveolar
epithelial apoptosis using cleaved caspase 3 immunohistochemis-
try. Lung sections from WT mice infected with X-31 displayed
strong immunofluorescence for cleaved caspase 3 in the alveolar
tissue (Figures 6A and C). By contrast, there was strikingly very
little immunofluorescence observed in similar lung sections
obtained from Nox22/y mice infected with X-31 (Figure 6B
and D).
Figure 2. Lung histology in response to H3N2 (X-31) influenza A virus infection. (A–D) Hematoxylin and eosin stained paraffin sections of
lungs from WT (A and B) and Nox22/y (C and D) mice obtained at Day 3. WT mice lungs had obvious peri-bronchial inflammation and prominent
bronchial infiltrates consisting of mononuclear cells and neutrophils. In contrast, Nox22/y mice displayed considerably less bronchial cell infiltrates
and peri-bronchial inflammation. Note, magnification of (A) and (C) is650 and (B) and (D) is6200.
doi:10.1371/journal.ppat.1001271.g002
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Examination of cytokine and chemokine expression in
lungs
We hypothesised that the reduced macrophage infiltrate
observed in Nox22/y mice following infection might be due to a
decrease in chemokines responsible for macrophage recruitment.
MCP-1 levels in WT lungs were significantly (P,0.05) increased 3
days post X-31 infection compared to naı¨ve controls (Figure 7A).
However, Nox22/y mice infected with X-31 virus had significantly
,40% lower levels of MCP-1 compared to X-31-infected WT
mice (Figure 7A). We also examined the expression of the cytokine
IL-1b, which has been shown to enhance influenza virus
clearance, protect from virus-induced mortality and stimulate
neutrophil recruitment [9], [10]. Following infection with X-31
virus, the levels of IL-1b mRNA expression in Nox22/y mouse
lungs were ,3-fold higher than that in WT lungs (Figure 7B). The
TNF-a expression level was also assessed given that it has been
previously implicated in influenza immunopathology. There was
no difference in TNF-a expression between Nox22/y mice and
WT mice (Figure 7C). There were no significant differences in
levels of MCP-1, IL-1b and TNFa between strains in naı¨ve mice
(Figure 7). We also explored whether there were changes in the
neutrophil chemoattractant KC. QPCR revealed a small and
significant increase in KC expression in both naı¨ve and X-31
infected Nox22/y mice lungs compared to WT lungs, which
supports the small, albeit insignificant increase in neutrophilia in
the Nox22/y lungs (Figure 7D).
Effect of Nox2 deletion on the magnitude and function
of influenza-specific CD8+ T cell response
NADPH oxidase-deficient T cells have been previously shown
to produce a Th1 skewed cytokine profile following TCR
stimulation with cross-linking antibody [11]. Therefore we
investigated the effect of Nox22/y deficiency on the magnitude
and polyfunctionality of two immunodominant CD8+ T cell
specificities. Tetramer staining of the BALF (Figure 8A–C) and
spleen (Figure 8D–F) showed no significant differences in CD8+ T
cell numbers between WT and Nox22/y animals. Furthermore
influenza-specific CD8+DbNP366+ and DbPA224+CD8+ T cells
were stimulated in vitro with relevant peptide and cytokine
expression (IFN-c, TNF-a and IL-2) detected using intracellular
cytokine staining. There were no differences in cytokine expression
observed between Nox22/y and WT animals (data not shown).
This suggests that absence of Nox2 does not affect CD8+ T cell
effector function.
Pharmacological inhibition of Nox2 in vivo protects
against X-31 and PR8 influenza virus-induced lung
inflammation and damage
As genetic deletion of Nox2 suppresses lung injury associated
with influenza A virus infection, we examined whether pharma-
cological inhibition of Nox2 in vivo with apocynin similarly protects
against X-31 influenza A virus infection. Apocynin treatment of
influenza A virus-infected WT mice resulted in significant
reductions in BALF cellularity and numbers of macrophages and
neutrophils (P,0.05) (Figure 9A). Basal and PDB-stimulated
superoxide production were significantly lower ,60% (P,0.05) in
BALF cells isolated from apocynin-treated mice than in cells from
untreated mice (Figure 9B). Strikingly, apocynin-treated mice
displayed ,50% reduction in viral titers when compared to
untreated controls indicating that apocynin not only has anti-
inflammatory properties but also facilitates virus clearance
(Figure 9C).
We also examined the effect of apocynin treatment following
PR8 influenza A virus infection in WT mice. As with X-31
infection, apocynin significantly suppressed BALF cellularity and
superoxide production (Figure 9D–E).
Nitrite levels were similar in BALF taken from X-31 and PR8
virus-infected control (18.9861.17 mM and 21.3165.23 mM,
respectively) and apocynin-treated mice (16.2361.11 mM and
17.1462.5 mM, respectively). (n = 4–7).
Discussion
The recent outbreak of pandemic H1N1 influenza A virus has
reinforced the urgent need for new pharmacological strategies that
not only reduce virus replication but also the often-lethal, lung
injury. Ideally, new therapies should show strong clinical efficacy
against emerging and seasonal influenza A virus strains. The
present study has shown that the absence of Nox2 (i.e. Nox22/y
mice) or inhibition of Nox2 activity (apocynin-treated mice)
substantially reduces inflammatory cell superoxide production,
lung peroxynitrite levels, airways inflammation and apoptosis
following infection with low and high pathogenicity influenza A
virus strains. Strikingly, it also enhances clearance of the virus.
Thus, modulation of Nox2 oxidase activity may represent a new
therapeutic approach for controlling the lung inflammation caused
by influenza A virus strains for which the population has no pre-
existing immunity.
Snelgrove et al., 2006 provided evidence for a significant
improvement in lung function and for a reduced level of lung
tissue damage in Nox22/2 mice following low pathogenicity
infection with X-31 influenza A virus [7]. In the present study we
utilized a dose of X-31 that causes substantially greater BALF
inflammation. We found that pulmonary challenge of wild type
mice with X-31 resulted in a substantial degree of lung
inflammation characterised by an accumulation of inflammatory
cells around the peri-bronchial regions. By contrast the same viral
infections caused markedly less peri-bronchial inflammation in
Nox22/y mice. It is widely regarded that influenza A virus
infection can cause extensive alveolar epithelial damage due to
apoptosis resulting in alveolar leakage and consequently lung
oedema and dysfunction [12]. In the present study, we show for
Figure 3. Superoxide production from BALF cells using L-O12-
enhanced chemiluminescence. BALF cells obtained from H3N2 (X-
31) influenza A virus-infected WT and Nox22/y mice 3 days post
infection. Data are shown as mean 6 SD relative light units per second
(RLU/s) for 6–8 mice per treatment group. *P,0.05 vs WT no virus mice,
#P,0.05 vs respective WT mice (ANOVA and Dunnett’s post hoc test).
doi:10.1371/journal.ppat.1001271.g003
Nox2 Oxidase and Influenza A Virus
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the first time a substantial reduction in alveolar epithelial apoptosis
in Nox22/y mice compared to WT controls. Previous studies
examining the effects of infection with the highly lethal avian
H5N1 virus in mice genetically deficient in the regulatory subunit
of Nox2 activity, p47phox, demonstrated similar protective effects
to those seen here in Nox22/y mice including significantly less
pulmonary oedema [4]. Thus, Nox2-containing NADPH oxidase
appears to be detrimental to the host following influenza A virus
infections that cause mild, modest and even severe lung injury [4],
[7].
The lethal lung pathology caused by pandemic strains of
influenza A virus is believed to be due, at least in part, to an
excessive host innate response characterized by a massive
infiltration of macrophages and neutrophils [2], [13]. Activated
macrophages and neutrophils produce large amounts of superox-
ide to limit the virus. However, in excess amounts, superoxide is
toxic and capable of inducing significant injury to surrounding
tissue. Indeed, this was exemplified by studies that showed that
mice survived a potentially lethal influenza A virus infection when
treated with pyran conjugated superoxide dismutase (SOD) to
inactivate superoxide [3]. Although superoxide possesses consid-
erable oxidising power to modify redox sensitive pathways and
cause oxidative damage to cells, its biological toxicity is most likely
due to its ability to rapidly give rise to a number of ROS and
reactive nitrogen species with greater oxidising capacity such as
OONO2.. These molecules have detrimental biological effects
including nitration and oxidation of macromolecules, including
proteins and DNA. Furthermore, it is well established that
peroxynitrite is a powerful stimulant of apoptosis via the caspase
3 pathway (for review see [14]). Previously, it was concluded that
one of the most important pathogenic factors in influenza A virus–
induced pneumonia is peroxynitrite [15]. In the present study we
show that the source of superoxide was solely Nox2 oxidase — as
BALF cells isolated from Nox22/y mice produced almost no
superoxide both basally and following stimulation with PDB.
Moreover, we show for the first time, substantially less peroxynitrite
in the lungs of Nox22/y mice compared to WT mice, indicating
unequivocally that Nox2 is the major source of peroxynitrite
induced by influenza A virus infection. Thus, it is highly likely that
the protective effects of Nox2 inhibition are due to a reduction in
superoxide and one of its major downstream derivatives,
peroxynitrite.
Figure 4. Peroxynitrite production in mouse lung infected with H3N2 (X-31) influenza A virus using 3-nitrotyrosine (3-NT)
immunofluorescence. Representative sections of lung tissue obtained from WT (A) and Nox22/y mice (B) infected with X-31 were incubated with
mouse monoclonal anti-3-nitrotyrosine antibody (1:50) followed by biotinylated anti-mouse IgG reagent. (C and D) The same sections showing
corresponding light microscope images. WT mice lung sections displayed strong immunofluorescence for 3-NT in the inflammatory cells that
infiltrated the airways and in the alveolar tissue. In contrast, Nox22/y mice displayed markedly less immunofluorescence for 3-NT.
doi:10.1371/journal.ppat.1001271.g004
Nox2 Oxidase and Influenza A Virus
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Figure 5. Effect of H3N2 (X-31) influenza A virus infection on viral titer and body weight in wild type (WT) andNox22/y mice. Mice were
treated with 16104 PFU of the low virulence H3N2 strain of influenza A virus and (A) viral titer determined 3 days post infection and (B) body weight
recorded for up to 7 days post infection. Data are shown as mean 6 SD for 6–8 mice per group. *P,0.05 vs WT mice (Students’ unpaired t test).
doi:10.1371/journal.ppat.1001271.g005
Figure 6. Cleaved caspase 3 immunofluorescence to assess lung alveolar epithelial apoptosis. Representative sections of lung tissue
obtained from WT (A) and Nox22/y mice (B) infected with influenza A virus (H3N2; X-31) were incubated with rabbit polyclonal anti-cleaved caspase 3
antibody (1:250) followed by goat anti-rabbit Alexa fluor 488 (Invitrogen; 1:500) secondary antibody. (C and D) The same sections showing
corresponding light microscope images. WT mice lung sections displayed strong immunofluorescence for cleaved caspase 3 in the alveolar tissue. In
contrast, Nox22/y mice displayed markedly less immunofluorescence for cleaved caspase 3.
doi:10.1371/journal.ppat.1001271.g006
Nox2 Oxidase and Influenza A Virus
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Although from the present study, it appears that Nox2 is the
predominant source of BALF inflammatory cell superoxide and
the major source of lung tissue peroxynitrite production following
influenza A virus infection, previous studies have implicated
xanthine oxidase expressed in airways epithelium as a source of
pathogenic superoxide [3]. Therefore, perhaps the most effica-
cious therapeutic approach against influenza A virus-induced lung
oxidative stress would be to abolish the activities of both Nox2-
containing NADPH oxidase and xanthine oxidase.
Pulmonary challenge with influenza A virus initiates a persistent
infiltration of cells into the lungs, which marks the beginning of the
innate immune response. Our study has shown that at 3 days post
infection, the predominant cell types in the airway are the
macrophages followed by neutrophils. By contrast, lungs of
infected Nox22/y mice had generally less cells compared with
wild type controls particularly at Day 7. Interestingly, this reduced
airways cellularity in Nox22/y lungs appeared to be due to a
specific reduction in macrophage numbers which were ,40%
lower than in wild type controls. The reason for a reduction in
macrophage numbers in Nox22/y lungs is likely due to a reduction
in their recruitment as levels of the chemotactic factor MCP-1 in
these lungs were significantly lower. Indeed, studies performed
with MCP-1 knockout mice showed a significant reduction in
macrophage recruitment into the lungs during influenza infection
[16]. MCP-1 production can occur in a number of cells including
the airways epithelium. Although ROS are classically considered
to cause lung damage when produced in excess because they are
toxic to cells, they may also be involved in signal transduction
pathways that regulate release of pathogenic cytokines such as
MCP-1 from airways epithelium. Irrespective of the mechanism of
ROS-dependent cytokine release, our study indicates that
inhibition of Nox2-derived ROS has the potential to reduce the
overall numbers of infiltrating inflammatory cells into the airways
and hence the overall immunopathological clinical features
induced by pandemic-inducing strains of influenza A viruses.
In this respect our study contradicts the Snelgrove et al. study in
that macrophage numbers and overall inflammatory cell numbers
were significantly lower in Nox22/y mice whereas Snelgrove et al.,
showed a heightened level of these cells. We hypothesize that
differences may be attributed to the gender of the host i.e. male
mice in our study as opposed to female mice by Snelgrove et al.,
2006 [7]. Although currently, we have no experimental evidence
to suggest a potential gender difference in the airways inflamma-
tion caused by influenza virus infection, we have previously
demonstrated a considerable gender difference in Nox2 activity
under the settings of experimental stroke in mice [17]. Specifically,
we showed that Nox2 oxidase activity in cerebral arteries is
substantially higher in male mice compared to female mice [17]. A
potential gender difference in the airways inflammation caused by
influenza A virus infection certainly warrants further investigation.
Our study reveals a protective anti-inflammatory effect of Nox2
inhibition that could potentially modulate the fatal immune
Figure 7. Assessment of lung cytokines levels. Effect of H3N2 (X-31) influenza A virus infection on (A) MCP-1, (B) IL-1b, (C) TNF-a and (D) KC
mRNA expression in whole lung obtained from WT and Nox22/y mice 3 days post infection. Responses are shown as fold change relative to 18S. Data
are shown as mean 6 SD of 4 individual mice. WT and Nox22/y mice are shown as open and filled histograms, respectively. WT mice that did not
receive H3N2 (i.e. naı¨ve mice) were used as a control to demonstrate that virus infection caused an increase in MCP-1, IL-1b, TNF-a and KC. *P,0.05 vs
respective naı¨ve mice (ANOVA and Dunnett’s post hoc test),#P,0.05 vs WT X-31-treated mice (ANOVA and Dunnett’s post hoc test). ** P,0.05 vs WT
naı¨ve mice.
doi:10.1371/journal.ppat.1001271.g007
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response triggered by pandemic influenza. That is, inhibition of
Nox2 not only suppresses the production of toxic ROS by
infiltrated macrophages and neutrophils but it also results in a
reduction in the actual numbers of these cells in the airways.
Although this would appear to be an attractive way of modulating
an aggressive host immune response triggered by influenza A
viruses, the dampening of this pro-inflammatory response might
be predicted to compromise the ability of the host to effectively
eliminate the virus. This has been well documented with the use of
immunomodulators such as the COX2 inhibitors celecoxib and
mesalazine, and for steroids. These compounds are effective at
suppressing the early innate immune response but this comes with
the cost of compromising viral clearance [18], [19]. In the present
study, we showed that Nox2 deletion results in a reduction in lung
viral titers. However, how inhibition of Nox2 derived ROS results
in a ‘paradoxical’ reduction in virus titer in the lungs is unknown,
for ROS are classically believed to be necessary for clearance of
pathogens. One possibility is that the protective effect of
superoxide inhibition is due to a resulting increase in bioavail-
ability of anti-viral NO (for review see [20]). In the present study
we show that NO levels in the BALF of Nox22/y mice are unlikely
to be different to WT mice, at least after 3 days post infection.
Whilst this appears surprising, it is consistent with previous reports
that have shown unequivocally that NO levels only seem to
increase in the lungs after 4 days post infection [15]. Thus, at least
at Day 3 post infection where we observe a considerable
improvement in outcome, NO is unlikely to be contributing to
this protection. Snelgrove et al proposed the reduced virus titers
were due to heightened macrophage numbers in the airways in the
Nox22/2 mice and presumably enhanced clearance of the virus
by these cells [7]. As mentioned, in the present study we show a
reduction in macrophages in the Nox22/y lungs, and thus, this is
unlikely to explain the reduction in viral titers observed here.
Although we currently have no experimental evidence to suggest
how suppression of Nox2 results in a reduction in viral titers, one
strong possibility is a reduction in virus replication within the
airways epithelium. A number of studies have shown evidence that
removal of ROS with antioxidants such as N-acetyl-cysteine
suppresses replication of influenza A viruses including H5N1 in
airway epithelial cells [21]. ROS are proliferative mediators and
Figure 8. Number of the CD8+ T cell response. Enriched CD8+ T cells from BALF (A–C) or spleen (D–F) were obtained from influenza A virus (X-
31)-infected WT and Nox22/y mice 7 days post infection. These were then stained with fluorescently labelled tetramer complexes specific for the two
immunodominant CD8+ T cell epitopes (DbNP366–372 and DbPA224–232) and data analysed by flow cytometry. Data are shown as mean 6 SD of 4
individual mice.
doi:10.1371/journal.ppat.1001271.g008
Nox2 Oxidase and Influenza A Virus
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thus, may be crucial for viruses to replicate within cells. Overall, it
appears that suppression of Nox2 and its production of ROS may
have a dual beneficial effect, which includes suppression of lung
apoptosis/inflammation and viral titers.
We also addressed whether inhibition of Nox2 influences
important processes of the adaptive immune system. For example,
does Nox2 oxidase play a role in antigen processing and
presentation to CD8+ T lymphocytes? [22]. This process is
crucial for effective activation of the adaptive immune response as
it stimulates proliferation of CD8+ T lymphocytes that recognize
viral antigens presented by infected cells. Snelgrove et al., 2006
showed a modest increase in CD8+ T cell numbers in the BALF of
Nox22/2 mice compared to WT mice and suggested this is likely
to explain the enhanced viral clearance in this strain of mice. In
the present study we quantified virus antigen specific CD8+ T
lymphocytes in the spleen and BALF using tetrameric complexes
targeting influenza-specific CD8+DbNP366+ and DbPA224+CD8+
T cells. Our findings indicate that in the absence of Nox2, antigen
specific T cell-mediated immunity is preserved.
To demonstrate therapeutic relevance of our findings, we
examined whether inhibition of Nox2 activity with apocynin
similarly protects against influenza A virus infection. Over the past
decade apocynin has gained recognition as the gold standard
inhibitor of Nox2 activity by preventing the association of p47phox
with the Nox2 subunit (for review see [5]). There have been
numerous reports describing a beneficial effect of apocynin in the
settings of hypertension, cerebral ischemia-reperfusion injury,
stroke outcome and myocardial infarction via its ability to inhibit
Nox2 [5]. In the present study, mice were treated with apocynin at
a dose (i.e. 2.5 mg/kg/day) shown previously to protect mice
against ischemia damage caused by stroke [23]. Importantly, the
effect of this dose of apocynin was similar to that seen in Nox22/y
mice and apocynin did not provide further protection in Nox22/y
mice, confirming a Nox2 specific action of apocynin [23]. Our
Figure 9. Pharmacological inhibition of Nox2 oxidase activity. Effect of apocynin (Apo, 2.5 mg/kg) treatment on (A) BALF cellularity, (B) BALF
inflammatory cell superoxide production and (C) viral titer in H3N2 (X-31) influenza A virus-infected WT mice 3 days post infection. Also, effect of
apocynin treatment on (D) BALF cellularity and (E) BALF inflammatory cell superoxide production in H1N1 (PR8) influenza A virus-infected WT mice 3
days post infection. Data are shown as mean6 SD for 6–8 mice per treatment group. *P,0.05 vs WT vehicle (Control)-treated mice (ANOVA followed
by Dunnett’s post hoc test for (A and D) but Students’ unpaired t test used for B, C and E).
doi:10.1371/journal.ppat.1001271.g009
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study shows that administration of apocynin causes a powerful
suppression of airways inflammation characterised by a decrease
in the infiltration of macrophages, and neutrophils. This
culminated in a substantial and visible reduction in oedematous
bloody lung tissue following PR8 infection. In addition, apocynin
significantly reduced virus titers. Thus, our study demonstrates an
important and potentially clinically attractive effect of apocynin.
That is, not only does apocynin possess potent anti-inflammatory
effects but also it has the ability to promote viral clearance. Future
studies will examine the use of apocynin, and other novel Nox2
inhibitors, as potential therapeutics.
To summarize, current strategies for the treatment of influenza
A virus-induced lung disease are focussed primarily at halting
mechanisms of viral infection and replication [24]. Far less
attention has been directed to investigating mechanisms that
modulate host responses, which lead to lung inflammation and
pathology. In the present study we evaluated the role of Nox2
oxidase, the primary source of ROS in immune cells in the lung
immunopathology caused by influenza A virus of varying
virulence. The absence of Nox2 reduced airways inflammation,
lung oxidative stress and apoptosis. Moreover, Nox2 may impede
with virus clearance and/or stimulate virus replication. We
envisage that use of Nox2 inhibitors, in combination with antiviral
strategies, may be effective tools against morbidity and mortality
induced by seasonal and pandemic stains of influenza A virus.
Materials and Methods
Animal breeding
Specific pathogen-free male C57BL/6 (wild type) and Nox2
deficient (Nox22/y) mice (C57BL/6 background) aged between 7
and 10 weeks and weighing,25 g were bred at the Department of
Pharmacology at Monash University. The animals were housed at
20uC on a 12 h day/night cycle in sterile micro-isolators and fed a
standard sterile diet of Purina mouse chow with water allowed ad
libitum.
Animal ethics statement
The experiments described in this manuscript were approved by
the Animal Experimentation Ethics Committee of The University
of Melbourne and conducted in compliance with the guidelines of
the National Health and Medical Research Council (NHMRC) of
Australia on animal experimentation.
Infection of WT and Nox22/y mice
Male naı¨ve WT control and Nox22/y mice were anaesthetized
by penthrane inhalation and infected intranasally (i.n.) with 16104
plaque forming units (PFU) X-31 (H3N2) or 50 PFU PR8 (H1N1)
in a 35 ml volume, diluted in PBS. All mice were killed at day 3
(peak of viral titres) or day 7 (resolution of infection) following
influenza infection.
In vivo pharmacological inhibition of Nox2
The Nox2 selective inhibitor, apocynin (2.5 mg/kg) was
administered to WT mice via intraperitoneal (i.p.) injection daily
for 3 days prior to either X-31 or PR8 influenza A virus infection,
and for up to 3 days following infection. We have previously
shown that 2.5 mg/kg apocynin can selectively inhibit Nox2
oxidase activity [23].
Airways inflammation and differential cell counting
Mice were killed by an i.p. injection of sodium pentobarbitone
(360 mg/kg) and BAL performed as we have previously shown
[25], [26]. Briefly, lungs from each mouse were lavaged in situ with
a 400 ml aliquot, followed by three 300 ml of PBS. The total
number of viable cells in the BALF was determined by using
ethidium bromide and acridine orange (Molecular Probes, San
Diego, USA) on a standard Neubauer hemocytometer using a
Zeiss Axioscope Fluorescence microscope. Cytospins were pre-
pared using 20–50 ml BALF at 350 rpm for 10 min on a Cytospin
3 (Shandon, UK). Cytospin preparations were stained with
DiffQuik (Dade Baxter, Australia) and 500 cells per slide were
differentiated into macrophages, neutrophils, eosinophils, and
lymphocytes by standard morphological criteria. The remaining
BALF was spun at 3000 rpm for 5 min to pellet cells for flow
cytometry and superoxide detection. In addition, the spleens of
virus-infected mice were collected for flow cytometry.
Histology
Histology was performed as previously described [26]. Briefly,
mice were killed by i.p. anaesthesia (360 mg/kg sodium pento-
barbitone) overdose and then perfusion fixed via a tracheal
cannula with 10% neutral buffered formalin at exactly 200mm
H2O pressure. After 10 min, the trachea was ligated, the lungs
were removed from the thorax and immersed in 10% neutral
buffered formalin for 24 h. After fixation of the lung tissue and
processing in paraffin wax, sections (3–4 mm thick) were cut
longitudinally through the left and right lung so as to include all
lobes. Sections were stained with hematoxylin and eosin (H&E) for
assessment of general histopathology.
Superoxide detection with L-O12 enhanced
chemiluminescence
BALF inflammatory cells were exposed to the chemiluminescent
probe, L-O12 (100 mM; Wako laboratories, Japan) in the absence
or presence of the PKC and NADPH oxidase activator, phorbol
dibutyrate (1 mM; Sigma) and dispensed into 96 well white opti-
plates for luminescence reading with the TopCount (Packard).
Photon emission was recorded from each well every 2 min and
averaged over 45min. Individual data points for each group were
derived from the average of 3 replicates. In some cases, cells were
incubated with superoxide dismutase (SOD; 600U/ml) to
inactivate superoxide and to verify that the L-O12 chemilumi-
nescence signal was due to superoxide.
Immunohistochemistry
Lung sections from WT and Nox22/y mice infected with X-
31 were deparaffinised and fixed in acetone for 15 min. Tissues
were then washed in 0.01 M phosphate buffered saline (PBS,
pH 7.4; 3610 min) before incubation in a Mouse on Mouse Ig
blocking reagent (Vector Laboratories) for 1 h to reduce non-
specific binding. Tissue mounted sections were incubated in
either mouse monoclonal anti-3-nitrotyrosine (1:50, AbCAM)
or rabbit polyclonal anti-cleaved caspase 3 antibody (1:250,
AbCAM) overnight in a humid box. The following day, tissues
were washed in 0.01 M PBS (3610 min) to remove any excess
antibody, and incubated in a biotinylated anti-mouse IgG
reagent for 10 min for 3-nitrotyrosine studies or a goat anti-
rabbit Alexa fluor 488 (Invitrogen; 1:500) secondary antibody
for caspase 3. Lung sections were then washed in 0.01 M PBS
(3610 min) and Fluorescein Avidin DCS (Vector Laboratories)
was applied for 5 min. Sections were washed in 0.01 M PBS
(3610 min) and cover slipped. Slides were viewed and
photographed on an Olympus fluorescence microscope.
Researchers were blinded throughout the experiment and all
the appropriate primary and secondary controls were per-
formed.
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Viral titres
Lungs from influenza virus-infected mice were removed,
weighed and homogenised in 2 ml of RPMI medium 1640
containing 24 mg/ml gentamycin and 100 units/ml penicillin/
streptomycin. Viral titres (PFU/ml) were determined by plaque
assay on Madin-Darby Canine Kidney (MDCK) cell monolayers
as previously published [27].
Griess reaction for nitrite determination
NO levels in BALF were determined by quantifying its product,
nitrite, using the Griess reaction kit according to the manufactur-
er’s instructions (Molecular Probes). Nitrite levels were determined
from 150 ml of BALF, which was obtained from WT and from
either Nox22/y or apocynin (2.5 mg/kg/day) treated mice killed
Day 3 post X-31 or PR8 infection.
Quantitative real-time PCR
Whole lungs were perfused free of blood via right ventricular
perfusion with 10 ml of pre-warmed saline, rapidly excised en bloc,
blotted and snap frozen in liquid nitrogen. Total RNA was extracted
from 15 mg of whole lung tissue pooled from 5 mice per treatment
group using RNeasy kits (Qiagen), reverse transcription with
SuperScript III (Invitrogen) and triplicate real time PCR reactions
with Applied Biosystems pre-developed assay reagents and 18S
rRNA internal control were done as previously described [25], [26].
Tetramer and intracellular cytokine staining
The numbers of BALF and spleen influenza-specific
CD8+DbNP366+ and DbPA224+ T cells was assessed using
tetramer and intracellular cytokine staining as we have previously
described. Splenocyte suspensions were initially depleted of B cells
by panning on 150-mm petri dishes coated with goat anti-mouse
IgG/IgM (Jackson ImmunoResearch, CA, USA) for 1 h at 37uC.
BALF was placed on plastic for 1 h at 37uC to remove
macrophage populations. Enriched CD8+ lymphocyte populations
from the spleen and BALF were then stained with fluorescently
labelled tetrameric complexes directed against two immunodomi-
nant influenza-specific CD8+ T cells epitopes (DbNP366–372 or
DbPA224–232) to determine the numbers of the responding
population. In addition, enriched CD8+ T cells were incubated
for 5 h in 96-well round bottom plates with 1 mM influenza
NP366–372 or PA224–232 peptide in the presence of Brefeldin and
IL-2 and then fixed and stained for the presence of CD8a, IFN-c,
TNF-a and IL-2 as previously described [28]. Data was acquired
on a BD FACS Calibur (Becton Dickinson, USA) and analysed
using Cell Quest Pro software.
Statistical analyses
As data were normally distributed, they are presented as
grouped data expressed as mean6standard deviation of the mean
(SD); n represents the number of mice. Differences in BALF cell
types and whole lung mRNA expression were determined by
analysis of variance (ANOVA) followed by Dunnett post hoc test for
multiple comparisons, where appropriate. In some cases, Student’s
unpaired t-test was used to determine if there were significant
differences between means of pairs. All statistical analyses were
performed using GraphPad Prism for Windows (Version 5.0). In
all cases, probability levels less than 0.05 (*P,0.05) were taken to
indicate statistical significance.
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